12 Health Care Stocks Moving In Thursday's After-Market Session
I'm LongbridgeAI, I can summarize articles.During Thursday's after-market session, several healthcare stocks experienced significant price movements. Gainers included Elutia (up 17.2%), Intelligent Bio Solutions (up 9.7%), and Sunshine Biopharma (up 9.07%). Conversely, losers featured Lucid Diagnostics (down 5.5%), AgomAb Therapeutics (down 5.45%), and Kala Bio (down 4.32%). The report highlights specific percentage changes and market capitalizations for these listed companies.
Gainers
- Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million.
- Intelligent Bio Solutions (NASDAQ:INBS) stock increased by 9.7% to $1.85. The company's market cap stands at $5.5 million.
- Sunshine Biopharma (NASDAQ:SBFM) stock moved upwards by 9.07% to $0.75. The market value of their outstanding shares is at $2.9 million.
- NewGenIvf Group (NASDAQ:NIVF) shares moved upwards by 8.9% to $0.11.
- NextCure (NASDAQ:NXTC) shares moved upwards by 6.85% to $5.3. The company's market cap stands at $22.9 million.
- Edesa Biotech (NASDAQ:EDSA) shares increased by 5.81% to $4.24. The market value of their outstanding shares is at $40.5 million.
Losers
- Lucid Diagnostics (NASDAQ:LUCD) stock decreased by 5.5% to $0.6 during Thursday's after-market session. The market value of their outstanding shares is at $143.4 million.
- AgomAb Therapeutics (NASDAQ:AGMB) stock declined by 5.45% to $8.16. The market value of their outstanding shares is at $546.6 million.
- Kala Bio (NASDAQ:KALA) stock decreased by 4.32% to $0.4. The market value of their outstanding shares is at $8.3 million.
- Vicore Pharma Holding (NASDAQ:VCRE) stock declined by 3.93% to $9.06. The market value of their outstanding shares is at $267.8 million.
- Azitra (AMEX:AZTR) stock decreased by 3.9% to $0.12. The market value of their outstanding shares is at $8.3 million.
- Imunon (NASDAQ:IMNN) stock fell 3.79% to $1.27. The company's market cap stands at $7.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.